The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s RNA-based colorectal cancer (CRC) screening test, ColoSense. The new kit enhances user ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback